Early Tumor Shrinkage (Ets) And Depth Of Response (Dpr) In Wild-Type (Wt) Ras Tumors From The Phase Iii Trial Of Panitumumab (Pmab) Plus Best Supportive Care (Bsc) Versus Bsc In Chemorefractory Metastatic Colorectal Cancer (Mcrc).
JOURNAL OF CLINICAL ONCOLOGY（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要